Cargando…
The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells
Mice transgenic for a c-myc gene driven by the IgH enhancer (E mu-myc) were shown to almost invariably develop lymphomas, 90% succumbing in the first 5 mo of life. The tumors typically presented as rapidly progressive lymphadenopathy with thymic involvement and were highly malignant by transplantati...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188841/ https://www.ncbi.nlm.nih.gov/pubmed/3258007 |
Ejemplares similares
-
Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice
Publicado: (1989) -
High frequency of myelomonocytic tumors in aging E mu L-myc transgenic mice
Publicado: (1992) -
Oncogene-linked in situ immunotherapy of pre-B lymphoma arising in E mu/ret transgenic mice.
por: Ichihara, M., et al.
Publicado: (1995) -
Strain‐dependency of Chromosomal Abnormalities in Lymphomas Developed in Eμ‐myc Transgenic Mice
por: Akagi, Kiwamu, et al.
Publicado: (2001) -
Strain Dependency of Cell‐type Specificity and Onset of Lymphoma Development in Eμ‐myc Transgenic Mice
por: Akagi, Kiwamu, et al.
Publicado: (1992)